Patent · US Active

Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)

US8518406B2 · kind B2 · utility

0Cited by

0References

26Claims

0Family size

Assignee

PROBIODRUG AG · DE

Inventors

Holger Cynis · Dohnsen, DE
Hans-Ulrich Demuth · Halle (Saale), DE
Jens-Ulrich Rahfeld · Lieskau, DE
Kathrin Gans · Halle (Saale), DE
Stephan Schilling · Halle (Saale), DE
Sonja Kampfer · Germering, DE

Key dates

Filing date	Aug 20, 2009
Grant date	Aug 27, 2013
Priority date	—
Expiry date	Oct 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Monoclonal antibodies which bind specifically to the proinflammatory cytokine pyroglutamate MCP-1 (MCP-1 N1pE) are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.